| |
Journal of Clinical Lipidology is the Official Journal of the National Lipid Association.
STATEMENT OF PURPOSE
The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the
incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism.
Journal of Clinical Lipidology
provides rapid online electronic and print publication of the most important current scientific developments in the field of lipids and
lipidology. The Journal publishes both clinical and basic original, peer-reviewed articles devoted to diagnosis and treatment
lipid disorders. Sections of the Journal address pioneering studies and the clinicians who conduct them, case studies, ethical
standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association
(NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held
by its chapters, when appropriate.
In general, review articles are invited, and unsolicited submissions will be considered. All articles
are sent for peer-review.
COPYRIGHT ASSIGNMENT
Authors are required to assign the copyright to the National Lipid Association
through publisher's copyright transfer form prior to publication.
GENERAL
Authors of manuscripts submitted to Journal
of Clinical Lipidology will receive a timely review and will be notified within two months as to whether their work is accepted, rejected,
or requires revision. Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical
Journals, available at: http://www.icmje.org.
PREVIOUS PUBLICATION OR DUPLICATE SUBMISSION:
Manuscripts are
considered with the understanding that they have not been published previously in print or electronic format and are not under consideration
by another publication or electronic medium. Copies of possibly duplicative materials (ie, those containing substantially similar content
or using the same or similar data) that have been previously published or are being considered elsewhere must be provided at the time
of manuscript submission.
PREVIOUS PRESENTATION OR RELEASE OF INFORMATION:
A complete report following presentation at
a meeting or publication of preliminary findings elsewhere (e.g. an abstract) can be considered. Media coverage of meeting presentations
will not jeopardize consideration, but direct release of information through press releases or news media briefings may preclude consideration
by the journal.
AUTHORSHIP:
Each author should have participated sufficiently in the work to take public responsibility
for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from
inception to publication. Authorship credit should be based on (1) substantial contributions to conception and design; (2) drafting the
article or revising it critically for important intellectual content; and (3) final approval of the version to be published. All conditions
must be met. Authors are required to identify their contributions to the work described in the manuscript.
CONFLICT OF INTEREST:
All authors must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or
is important to the outcome of the study presented. This would include funding for the research, membership in any speaker's bureau or
corporate advisory committee, stockholder, or support for travel. Authors should also disclose conflict of interest with products that
compete with those mentioned in their manuscript. The Editor will discuss with the authors on an individual basis the method by which
any conflicts of interest will be communicated to readers. Manuscripts without conflicts of interest disclosure from all authors will
be returned.
MANUSCRIPT and FIGURE PREPARATION (See manuscript format and categories for further details)
Manuscripts
must be submitted via the Elsevier Editorial System (EES) website for this journal; go to http://ees.elsevier.com/jclinlipid/
and select "Submit Manuscript". You will be guided stepwise through the creation and uploading of the various files and data. Once the
uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence
regarding submitted manuscripts will be handled via e-mail through EES.
For text files, Microsoft Word is preferred, although any
editable text file is acceptable (e.g., .doc, .txt, .rtf). Do not embed artwork with text. Separate files for each figure are required.
TIF or EPS figure files are strongly preferred, at the standard resolutions (i.e. 300 dpi for photos, 1200 dpi for line art) and scaled
to size. Other figure formats may be supported provided artwork guidelines on http://ees.elsevier.com/jclinlipid/
are strictly
followed. PDF files cannot be used for typesetting purposes for either text or figures. Arrange the contents in the following order:
1. Cover letter;
2 Title page (Include degrees for all authors and corresponding author contact information, and all conflicts
of interest);
3. Abstract (Required for original and review articles);
4. Key words (5-10);
5. List of abbreviations used
in the manuscript (Use ONLY those that are commonly accepted.);
6. Text (Double-spaced, single columned with a minimum of 1-inch
margins on all four edges;
7. References (Cite all authors);
8. Tables;
9. Figure legends;
10. Figures (save each
as a separate file for upload, Figures (save each as a separate file for upload, or compress all into one ZIP file for upload; the system
will "unpack" a .zip file automatically and allow you to properly identify each figure file. Go to www.winzip.com
for a free trial of this compression software.)
MULTIMEDIA COMPONENTS
Images
Submissions to "Multimedia Library:
Images and Videos" are limited to 1, double-spaced typewritten narrative (495 words for a 1 column figure; 425 words for a 1½
column figure), and no more than 2 illustration panels and 4 authors. Figure legends should not be used, but up to 5 reference citations
are permitted. Images are judged according to their aesthetic quality, the importance and effectiveness of their scientific or clinical
message, or their utility as a teaching tool. Unlike case reports, the focus should be on the image, not the narrative.
Authors can
also include a single electronic movie (e.g. Quicktime or MPEG1 formats) file or computer animation (e.g. as Power Point file) that expands
or enhances the message of the printed images. Submissions need not necessarily convey entirely novel findings so long as the animations
or movies are judged to provide novel or especially useful means of conveying known principles (e.g. Animations or movies that effectively
teach/portray an electrophysiological mechanism or process). If an electronic movie or animation is submitted, the authors must also
provide 1 or 2 frames of images (which will appear in print) that convey the essence of the movie's content.
Published images, movies,
and animations will be made available via the Journal's web site to subscribers to the Journal of Clinical Lipidology.
MANUSCRIPT FORMAT
Cover letter:
Manuscripts submitted must be original, with no portion under simultaneous consideration
for publication elsewhere or previously published, except for an abstract of fewer than 400 words. Studies involving experimental animals
and humans must conform to the guiding principles of the Declaration of Helsinki, and human subjects must have given informed consent
of a study that has been approved by the Institutional Committee on Human Research at the authors' institution. Any financial or other
relations must be disclosed. Cover letters must include affirmation of the above.
Title Page:
Please include
a brief and descriptive title of the article, a short title of fewer than 50 characters, authors full names, academic degrees, hospital
and academic affiliations, acknowledgment of ALL sources of financial support, potential conflicts of interests for all authors, and
the name, address, phone and fax numbers, and E-mail of the individual responsible for editorial correspondence and/or reprint requests.
Please upload title page separately from the manuscript.
Abstract (page 1): Please include a brief abstract (without references)
of fewer than 250 words for Original Articles. Divide the abstract into sections: Background, Objective, Methods, Results, and Conclusion
that states the importance and potential implications of the observations. Following the abstract, list 5 to 10 key words suitable for
indexing.
For Reviews and Case Studies, please follow the format instructions below:
Reviews: (250 words) Background (justify
relevance to readership), Sources of material, abstract of findings and conclusion.
Case Studies: Brief of overview of the problem
and major management decisions required o resolve the case.
Glossary of abbreviations used in the manuscript: Avoid ALL abbreviations
other than standard units of measurement and common abbreviations, such as RV, LV, etc.
Text:
Begin the text on page
3 and organize into sections: Introduction, Methods, Results, Discussion, and Conclusion, with appropriate subheadings to make
the sections easily understood. Explain abbreviations at first mention, followed by the abbreviation in parentheses. References, tables,
and figures should be cited in numerical order. Avoid jargon, cliches, and laboratory slang. References to medical devices, equipment
and drugs must adhere to code structures and usage conventions set forth by NLA code. Place acknowledgments at the end of the text, before
references. The manuscript should not exceed 20 double-spaced typed pages, 8 figures, 3 tables, and 35 references. Authors whose native
language is not English are STRONGLY advised to seek appropriate grammatical assistance. Poorly written manuscripts are at a disadvantage.
Do not include any author contact information within the text.
References:
Number references in numerical order in the
text. Include references to unpublished material or personal communications in the text in parentheses. Abbreviate titles of periodicals
according to the style of Index Medicus, National Library of Medicine. List all authors in each reference following exactly
the format and punctuation shown below.
Journal Article-Example
Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P,
Makikallio TH, Juhani Airaksinen KE, Myerburg RJ: Prediction of sudden cardiac death after myocardial infarction in the beta-blocking
era. J Am Coll Cardiol. 2003;42:652-8.
Chapter in Book with Different Author and Editor-Example
La Rovere MT, Schwartz
PJ. Baroreflex sensitivity. In: Opie L, ed. Drugs for the Heart. 6th ed. Philadelphia: WB Saunders; 2006:67-93.
Please note
that the Journal of Clinical Lipidology's reference style is now included in the EndNote® bibliographic system. Authors
are responsible for the accuracy and completeness of their references and for correct text citation.
Tables:
Tables
must be self-explanatory and supplement, not duplicate, the text. Number brief titles in Arabic numerals according to the order of mention
in the text. Each table should be typed on a separate page and designed for economy of space and readability. Do not imbed tables within
the text. Notes designated in the tables and all abbreviations should be defined in a footnote. Abbreviations should be identified in
alphabetical order. Footnotes should be used in the following order: *,†, ‡, §, ||, ¶, #
Figure
Legends/Figures:
(See detailed figure requirements under manuscript and figure preparation).
Manuscripts with incorrect
format or that are over maximum length will be returned unreviewed
Permissions:
Authors must submit written permission
upon manuscript submission from both the author and publisher of the original source when material is reproduced from other
sources. This permission must include reproduction in both print and electronic formats for worldwide distribution.
Acknowledgements:
Acknowledgement(s) require written permission of the person being acknowledged.
Proofs:
To avoid publication delay,
authors must return proofs in 48 hours.
Responsibility:
Manuscripts are subject to editorial modification to bring
them into conformity with the style of the journal. Statements in articles or opinions expressed by any contributor in any article, including
changes made by the copy editor and approved by the corresponding author, are not the responsibility of the editors or the publishers.
Manuscript Categories:
Original Contribution
Case Studies. Case studies are limited to 4 authors,
8 double-spaced pages total, including text, references (<20), figure legends, and 4 figures. No abstract included.
Reviews.
Contemporary and Historical Reviews (Solicited and Unsolicited)
Review articles should contain a brief abstract and be 5000
total words, including references, tables, and figures. References are 30 and must be 5 years old. Use other articles to incorporate
older references.
Letters to the Editor. Letters should be double-spaced, not exceeding 450words. Letters will be reviewed
and are subject to editing. They should not contain original data or figures. If accepted for publication, a copy of the letter will
be sent to the author(s) of the original article, if applicable. The author(s) will have an opportunity to respond with new material
that will be considered for publication with the letter.
Editorial Commentary. All articles by invitation only
Commentaries
should be confined to articles in the current issue or a very specific topic that is current and high interest to the readership.
News from the NLA.
Critique of Recent Publications: This should be a commentary on recent publications that are
of very high interest to the readership such as large trials of lipid altering drugs, new laboratory methods, and new genetic linkage
studies of lipid disorders. The author should be invited based on intimate knowledge of the area of study and an understanding of the
implications of the clinical impact. The Critique should give: title, reference, study question, major methods, results, conclusion
of the authors, and an opinion statement as to the impact this will have on our thought process and/or our actions in the clinical arena.
This should be limited to approximately 5 publications within the previous 6 months. The 5 publications/articles to be critiqued should
be construed as essential material that all clinical lipidologists should know in some detail. The abstracts for these areas should be
organized like those for the Review Articles. Examples of topics to be addressed include:
New Pharmacology.
Provide
a discussion of new drugs in development or new important discoveries regarding drugs that are already available. Please emphasize those
drugs that are nearing completion of Phase 3 in the FDA approval process.
New from the Laboratory.
Short articles (up
to 2 typeset pages) on laboratory developments (of great interest and relevance to the clinician) focusing on the issues of clinical
utility, accuracy, positive predictive value etc. (an example for this section: should we be using apolipoprotein measures, inflammatory
markers, diagnostic indicators for sub-clinical vascular disease, etc.)
Patient Education and Lifestyle.
This area
brings in many of the issues for the dietitian and nurse educator. New OTC agents, dietary issues, drug compliance, exercise benefits.
Updated
April 2009
|
| |
|
